Studies

CellWell record HH-431396

Fecal Microbiota Transplantation and Microbiota-Based Therapeutics in Allogeneic Hematopoietic Stem Cell Transplantation: Current Evidence and Future Directions

Bálint Gergely Szabó; Dorina Korózs; Michal Bator; Krisztina Jeszenszky; Viktor Lakatos; László Gopcsa; Péter Reményi; János Sinkó

2026

In plain language

This narrative review found that fecal microbiota transplantation is feasible in selected patients undergoing stem cell transplant and may benefit recurrent C. difficile infection and steroid-refractory gut graft-versus-host disease, based mostly on small studies.

Evidence
Emerging
Design
Expert review

Read it on PubMed

Powered by CellWell

Cite this record: https://thecellwell.org/studies/HH-431396

Produced by the CellWell Research Engine, custom software owned and operated by CellWell. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.

This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.